Cited by 1,518Neuroscience and Neuropharmacology ResearchAmino Acid Enzymes and MetabolismNeuroprotection in Cerebral Ischemia

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression

Rothstein, Jeffrey D., Patel, Sarjubhai, Regan, Melissa R., Haenggeli, Christine, Huang, Yanhua H., Bergles, Dwight E., Jin, Lin, Dykes Hoberg, Margaret, Vidensky, Svetlana, Chung, Dorothy S., Toan, Shuy Vang, Bruijn, Lucie I., Su, Zao-zhong, Gupta, Pankaj, Fisher, Paul B.·2005·Nature

DOI 10.1038/nature03180

Open this paper in CoChat — free account

Abstract

Glutamate is the principal excitatory neurotransmitter in the nervous system. Inactivation of synaptic glutamate is handled by the glutamate transporter GLT1 (also known as EAAT2; refs 1, 2), the physiologically dominant astroglial protein. In spite of its critical importance in normal and abnormal synaptic activity, no practical pharmaceutical can positively modulate this protein. Animal studies show that the protein is important for normal excitatory synaptic transmission, while its dysfunction is implicated in acute and chronic neurological disorders, including amyotrophic lateral sclerosis (ALS), stroke, brain tumours and epilepsy. Using a blinded screen of 1,040 FDA-approved drugs and nutritionals, we discovered that many beta-lactam antibiotics are potent stimulators of GLT1 expression. Furthermore, this action appears to be mediated through increased transcription of the GLT1 gene. beta-Lactams and various semi-synthetic derivatives are potent antibiotics that act to inhibit bacterial synthetic pathways. When delivered to animals, the beta-lactam ceftriaxone increased both brain expression of GLT1 and its biochemical and functional activity. Glutamate transporters are important in preventing glutamate neurotoxicity. Ceftriaxone was neuroprotective in vitro when used in models of ischaemic injury and motor neuron degeneration, both based in part on glutamate toxicity. When used in an animal model of the fatal disease ALS, the drug delayed loss of neurons and muscle strength, and increased mouse survival. Thus these studies provide a class of potential neurotherapeutics that act to modulate the expression of glutamate neurotransmitter transporters via gene activation.

Integrity signals

Registry

Crossref · 10.1038/nature03180

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,796
Glutamate uptake
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate
Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kuncl, R. W., Kanai, Y., Hediger, M. A., Wang, Y., Schielke, J. P., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80086-0 · Cited by 2,534
Self-citation
Epilepsy and Exacerbation of Brain Injury in Mice Lacking the Glutamate Transporter GLT-1
Tanaka, K., Watase, K., Manabe, T., Yamada, K., Watanabe, M., Takahashi, K., Iwama, H., Nishikawa, T., Ichihara, N., Kikuchi, T., et al. (1997) · Science · doi:10.1126/science.276.5319.1699 · Cited by 1,755
Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis
Rothstein, J. D., Van Kammen, M., Levey, A. I., Martin, L. J., & Kuncl, R. W. (1995) · Annals of Neurology · doi:10.1002/ana.410380114 · Cited by 1,471
Self-citation
Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral Sclerosis
Rothstein, J. D., Martin, L. J., & Kuncl, R. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205283262204 · Cited by 1,197
Self-citation
Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)
Howland, D., Liu, J., She, Y., Goad, B., Maragakis, N. J., Kim, B. B., Erickson, J., Kulik, J., DeVito, L., Psaltis, G. C., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032539299 · Cited by 890
Self-citation
Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model
Kaspar, B. K., Lladó, J., Sherkat, N., Rothstein, J. D., & Gage, F. H. (2003) · Science · doi:10.1126/science.1086137 · Cited by 872
Self-citation
Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity.
Rothstein, J. D., Jin, L., Dykes‐Hoberg, M., & Kuncl, R. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6591 · Cited by 623
Self-citation

Flagged first, then by citations

Show all 27 references

Sorted by citations

Items 601–700 of 1,000

GLT-1 promoter activity in astrocytes and neurons of mouse hippocampus and somatic sensory cortex
de Vivo, L. (2010) · Frontiers in Neuroanatomy · doi:10.3389/neuro.05.031.2009 · Cited by 42
β-lactamase inhibitors display anti-seizure properties in an invertebrate assay
Rawls, S. M., Karaca, F., Madhani, I. C., Bhojani, V., Martinez, R. L., Abou-Gharbia, M. A., & Raffa, R. B. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.06.041 · Cited by 40
Increased glial glutamate transporter EAAT2 expression reduces visceral nociceptive response in mice
Lin, Y., Tian, G., Roman, K., Handy, C. R., Travers, J. B., Lin, C.-L. G., & Stephens, R. L. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90556.2008 · Cited by 40
Anti-allodynic and anti-hyperalgesic effects of ceftriaxone in streptozocin-induced diabetic rats
Gündüz, Ö., Oltulu, Ç., Buldum, D., Guven, R., & Ulugöl, A. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2010.12.063 · Cited by 40
Antihyperalgesic/Antinociceptive Effects of Ceftriaxone and Its Synergistic Interactions with Different Analgesics in Inflammatory Pain in Rodents
Stepanović-Petrović, R. M., Micov, A. M., Tomic´, M. A., ́, J. M. K., & Bošković, B. (2013) · Anesthesiology · doi:10.1097/aln.0000435833.33515.ba · Cited by 41
Ceftriaxone Prevents the Neurodegeneration and Decreased Neurogenesis Seen in a Parkinson’s Disease Rat Model: An Immunohistochemical and MRI Study
Weng, J.-C., Tikhonova, M. A., Chen, J.-H., Shen, M.-S., Meng, W.-Y., Chang, Y.-T., Chen, K.-H., Liang, K.-C., Hung, C.-S., Amstislavskaya, T. G., et al. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.02.034 · Cited by 39
Ceftriaxone Protects Astrocytes from MPP+ via Suppression of NF-ΚB/JNK/c-Jun Signaling
Zhang, Y., Zhang, X., & Qu, S. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8845-z · Cited by 39
Cocaine-induced neuroadaptations in the dorsal striatum: Glutamate dynamics and behavioral sensitization
Parikh, V., Naughton, S. X., Shi, X., Kelley, L. K., Yegla, B., Tallarida, C. S., Rawls, S. M., & Unterwald, E. M. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.05.016 · Cited by 42
Hydrothermal synthesis of porous rh-In 2 O 3 nanostructures with visible-light-driven photocatalytic degradation of tetracycline
Wu, M., Wang, C., Zhao, Y. J., Xiao, L., Zhang, C., Yu, X., Luo, B., Hu, B., Fan, W., & Shi, W. (2015) · CrystEngComm · doi:10.1039/c4ce02262a · Cited by 39
Experimental trials in amyotrophic lateral sclerosis: a review of recently completed, ongoing and planned trials using existing and novel drugs
Goyal, N., & Mozaffar, T. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.933807 · Cited by 40
Corticostriatal circuitry in regulating diseases characterized by intrusive thinking
Kalivas, B. C., & Kalivas, P. W. (2016) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2016.18.1/pkalivas · Cited by 43
Ceftriaxone as a Novel Therapeutic Agent for Hyperglutamatergic States: Bridging the Gap Between Preclinical Results and Clinical Translation
Abulseoud, O. A., Alasmari, F. F., Hussein, A. M., & Sari, Y. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.841036 · Cited by 40
Increased expression of glutamate transporters in subcortical white matter after transient focal cerebral ischemia
Arranz, A. M., Gottlieb, M., Pérez‐Cerdá, F., & Matute, C. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.09.019 · Cited by 39
Reduced VGLUT2 expression increases motor neuron viability in Sod1G93A mice
Wootz, H., Enjin, A., Wallén‐Mackenzie, Å., Lindholm, D., & Kullander, K. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.09.006 · Cited by 39
Iron is a potential key mediator of glutamate excitotoxicity in spinal cord motor neurons
Yu, J., Guo, Y., Sun, M., Li, B., Zhang, Y., & Li, C. (2008) · Brain Research · doi:10.1016/j.brainres.2008.12.030 · Cited by 44
In vitro treatments with ceftriaxone promote elimination of mutant glial fibrillary acidic protein and transcription down-regulation
Bachetti, T., Zanni, E. D., Balbi, P., Bocca, P., Prigione, I., Deiana, G. A., Rezzani, A., Ceccherini, I., & Sechi, G. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.05.005 · Cited by 39
Issues in the Diagnosis and Treatment of Lyme Disease
Donta, S. T. (2012) · The Open Neurology Journal · doi:10.2174/1874205x01206010140 · Cited by 39
Glutamate transporter subtype 1 (GLT-1) activator ceftriaxone attenuates amphetamine-induced hyperactivity and behavioral sensitization in rats
Rasmussen, B. A., Unterwald, E. M., & Rawls, S. M. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.03.022 · Cited by 38
Effects of Administered Ethanol and Methamphetamine on Glial Glutamate Transporters in Rat Striatum and Hippocampus
Alshehri, F. S., Althobaiti, Y. S., & Sari, Y. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0859-8 · Cited by 40
Palladium-Catalyzed, Multicomponent Approach to β-Lactams via Aryl Halide Carbonylation
Torres, G. M., Macias, M. D. L. H., Quesnel, J. S., Williams, O. P., Yempally, V., Bengali, A. A., & Arndtsen, B. A. (2016) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.6b02405 · Cited by 38
Progress in Asymmetric Organocatalytic Synthesis of β‐Lactams
Magriotis, P. Α. (2014) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201301720 · Cited by 38
Effects of (R)‐(−)‐5‐methyl‐1‐nicotinoyl‐2‐pyrazoline on glutamate transporter 1 and cysteine/glutamate exchanger as well as ethanol drinking behavior in male, alcohol‐preferring rats
Aal-Aaboda, M. S., Alhaddad, H., Osowik, F. A., Nauli, S. M., & Sari, Y. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23554 · Cited by 37
Ceftriaxone Preserves Glutamate Transporters and Prevents Intermittent Hypoxia-Induced Vulnerability to Brain Excitotoxic Injury
Jagadapillai, R., Mellen, N. M., Sachleben, L. R., & Gozal, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100230 · Cited by 40
The beta-lactam antibiotic, ceftriaxone, inhibits the development of opioid-induced hyperalgesia in mice
Chen, Z., He, Y. Z., & Wang, Z. J. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.12.029 · Cited by 37
PET imaging studies show enhanced expression of mGluR5 and inflammatory response during progressive degeneration in ALS mouse model expressing SOD1-G93A gene
Brownell, A., Kuruppu, D., Kil, K.-E., Jokivarsi, K. T., Poutiainen, P., Zhu, A., & Maxwell, M. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0439-9 · Cited by 37
Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator
Gregg, R. A., Hicks, C., Nayak, S. U., Tallarida, C. S., Nucero, P., Smith, G. R., Reitz, A. B., & Rawls, S. M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.014 · Cited by 37
Corticostriatal network dysfunction in Huntington's disease: Deficits in neural processing, glutamate transport, and ascorbate release
Rebec, G. V. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12828 · Cited by 33
Loss of liver X receptor β in astrocytes leads to anxiety-like behaviors via regulating synaptic transmission in the medial prefrontal cortex in mice
Li, X., Zhong, H., Wang, Z., Xiao, R., Antonson, P., Liu, T., Chuan, W., Zou, J., Wang, L. Y., Nalvarte, I., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01139-5 · Cited by 39
Challenges and Opportunities of Targeting Astrocytes to Halt Neurodegenerative Disorders
Valori, C. F., Possenti, A., Brambilla, L., & Rossi, D. (2021) · Cells · doi:10.3390/cells10082019 · Cited by 39
Role of GLT-1 transporter activation in prevention of cannabinoid tolerance by the beta-lactam antibiotic, ceftriaxone, in mice
Gündüz, Ö., Oltulu, Ç., & Ulugöl, A. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.04.012 · Cited by 37
β-Lactam antibiotic inhibits development of morphine physical dependence in rats
Rawls, S. M., Baron, D. A., & Kim, J. K. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328337be10 · Cited by 37
Ceftriaxone Reverses Deficits of Behavior and Neurogenesis in an MPTP-Induced Rat Model of Parkinson’s Disease Dementia
Hsieh, M.-H., Meng, W.-Y., Liao, W.-C., Weng, J.-C., Li, H.-H., Su, H.-L., Lin, C.-L., Hung, C.-S., & Ho, Y.-J. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.05.015 · Cited by 35
Regulation of the Glutamate Transporters by JAK2
Hosseinzadeh, Z., Bhavsar, S. K., Sopjani, M., Alesutan, I., Saxena, A., Dërmaku‐Sopjani, M., & Lang, F. J. W. (2011) · Cellular Physiology and Biochemistry · doi:10.1159/000335763 · Cited by 36
GLT‐1 upregulation impairs prepulse inhibition of the startle reflex in adult rats
Bellesi, M., Melone, M., Gubbini, A., Battistacci, S., & Conti, F. (2008) · Glia · doi:10.1002/glia.20798 · Cited by 36
Drug Repositioning: Playing Dirty to Kill Pain
Bastos, L. F. S., & Coelho, M. M. (2013) · CNS Drugs · doi:10.1007/s40263-013-0128-0 · Cited by 36
Altered astrocytic response to activation in SOD1G93A mice and its implications on amyotrophic lateral sclerosis pathogenesis
Benkler, C., Ben‐Zur, T., Barhum, Y., & Offen, D. (2012) · Glia · doi:10.1002/glia.22428 · Cited by 69
Selected statins produce rapid spinal motor neuron loss in vitro
Murinson, B. B., Haughey, N. J., & Maragakis, N. J. (2012) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-13-100 · Cited by 36
SMN-Inducing Compounds For The Treatment Of Spinal Muscular Atrophy
Lorson, M. A., & Lorson, C. L. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.131 · Cited by 36
Peripheral and Central Glutamate Dyshomeostasis in Neurodegenerative Disorders
Onaolapo, A. Y., & Onaolapo, O. J. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666201015161919 · Cited by 37
The Effect of GLT-1 Upregulation on Extracellular Glutamate Dynamics
Wilkie, C. M., Barron, J. C., Brymer, K. J., Barnes, J. R., Nafar, F., & Parsons, M. P. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.661412 · Cited by 35
Decreased EAAT2 protein expression in the essential tremor cerebellar cortex
Lee, M., Cheng, M. M., Lin, C.-Y. R., Louis, E. D., Faust, P. L., & Kuo, S. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0157-z · Cited by 36
Oxidative and excitotoxic insults exert differential effects on spinal motoneurons and astrocytic glutamate transporters: Implications for the role of astrogliosis in amyotrophic lateral sclerosis
Zagami, C. J., Beart, P. M., Wallis, N., Nagley, P., & O’Shea, R. D. (2008) · Glia · doi:10.1002/glia.20739 · Cited by 36
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
Berry, J. D., & Cudkowicz, M. (2011) · Clinical Investigation · doi:10.4155/cli.11.127 · Cited by 36
Glutamate Transporter GLT-1 Upregulation Attenuates Visceral Nociception and Hyperalgesia via Spinal Mechanisms Not Related to Anti-Inflammatory or Probiotic Effects
Lin, Y., Roman, K., Foust, K. D., Kaspar, B. K., Bailey, M. T., & Stephens, R. L. (2011) · Pain Research and Treatment · doi:10.1155/2011/507029 · Cited by 36
Effects of ceftriaxone on hydrocodone seeking behavior and glial glutamate transporters in P rats
Alshehri, F. S., Hakami, A. Y., Althobaiti, Y. S., & Sari, Y. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.03.043 · Cited by 36
Cell-to-Cell Communications among Microorganisms
Horinouchi, S., Uéda, K., Nakayama, J., & Ikeda, T. (2010) · Elsevier eBooks · doi:10.1016/b978-008045382-8.00098-8 · Cited by 36
A New Avenue for Treating Neuronal Diseases: Ceftriaxone, an Old Antibiotic Demonstrating Behavioral Neuronal Effects
Tai, C.-H., Bellesi, M., Chen, A.-C., Lin, C.-L., Li, H.-H., Lin, P.-J., Liao, W.-C., Hung, C.-S., Schwarting, R. K., & Ho, Y.-J. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.02.020 · Cited by 34
RETRACTED: Matrine regulates glutamate-related excitotoxic factors in experimental autoimmune encephalomyelitis
Kan, Q., Zhang, S., Xu, Y., Zhang, G., & Zhu, L. D. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.12.031 · Cited by 35
Retracted
Clavulanic acid reduces rewarding, hyperthermic and locomotor-sensitizing effects of morphine in rats: A new indication for an old drug?
Schroeder, J. A., Tolman, N. G., McKenna, F. F., Watkins, K. L., Passeri, S. M., Hsu, A. H., Shinn, B. R., & Rawls, S. M. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.05.012 · Cited by 35
Organocatalyzed Three-Component Ugi and Passerini Reactions of 4-Oxoazetidine-2-carbaldehydes and Azetidine-2,3-diones. Application to the Synthesis of γ-Lactams and γ-Lactones
Alcaide, B., Almendros, P., Aragoncillo, C., Callejo, R., & Ruiz, M. P. (2013) · The Journal of Organic Chemistry · doi:10.1021/jo4015358 · Cited by 35
Role of Glutamatergic Excitotoxicity in Neuromyelitis Optica Spectrum Disorders
da Silva, A. P. B., de Souza, D. G., Souza, D. O., Machado, D. C., & Sato, D. K. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00142 · Cited by 35
Progress in progestin-based therapies for neurological disorders
Sitruk-Ware, R. L., Bonsack, B., Brinton, R. D., Schumacher, M., Kumar, N., Lee, J.-Y., Castelli, V., Corey, S., Coats, A. B., Sadanandan, N., et al. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.12.007 · Cited by 36
Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection
Pirooznia, S. K., Rosenthal, L. S., Dawson, V. L., & Dawson, T. M. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000189 · Cited by 36
Analgesic Effect of a Single Preoperative Dose of the Antibiotic Ceftriaxone in Humans
Macaluso, A., Bernabucci, M., Trabucco, A., Ciolli, L., Troisi, F., Baldini, R., Gradini, R., Battaglia, G., Nicoletti, F., & Collini, S. (2013) · Journal of Pain · doi:10.1016/j.jpain.2013.01.774 · Cited by 35
Astrocytic glutamate transporter-dependent neuroprotection against glutamate toxicity: An in vitro study of maslinic acid
Qian, Y., Guan, T., Tang, X., Huang, L., Huang, M., Li, Y., Sun, H., Yu, R. M., & Zhang, F. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.10.095 · Cited by 35
The β-lactam antibiotic ceftriaxone inhibits physical dependence and abstinence-induced withdrawal from cocaine, amphetamine, methamphetamine, and clorazepate in planarians
Rawls, S. M., Cavallo, F., Capasso, A., Ding, Z., & Raffa, R. B. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.02.018 · Cited by 35
The transcription factor Pax6 contributes to the induction of GLT‐1 expression in astrocytes through an interaction with a distal enhancer element
Ghosh, M., Lane, M. C., Krizman, E. N., Sattler, R., Rothstein, J. D., & Robinson, M. B. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13406 · Cited by 35
Self-citation
AEG-1/MTDH/LYRIC
Emdad, L., Das, S. K., Hu, B., Kegelman, T. P., Kang, D., Lee, S., Sarkar, D., & Fisher, P. B. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.05.002 · Cited by 35
Self-citation
Region-Specific Characteristics of Astrocytes and Microglia: A Possible Involvement in Aging and Diseases
Lee, J., Kim, S. W., & Kim, K.-T. (2022) · Cells · doi:10.3390/cells11121902 · Cited by 34
Translating preclinical insights into effective human trials in ALS
DiBernardo, A., & Cudkowicz, M. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.03.007 · Cited by 34
Ceftriaxone protects against the neurotoxicity of human immunodeficiency virus proteins
Rumbaugh, J. A., Li, G., Rothstein, J. D., & Nath, A. (2007) · Journal of NeuroVirology · doi:10.1080/13550280601178218 · Cited by 34
Self-citation
In vitro evidence for impaired neuroprotective capacities of adult mesenchymal stem cells derived from a rat model of familial amyotrophic lateral sclerosis (hSOD1G93A)
Boucherie, C., Caumont, A., Maloteaux, J., & Hermans, E. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.04.030 · Cited by 34
Ceftriaxone, a Beta-Lactam Antibiotic, Modulates Apoptosis Pathways and Oxidative Stress in a Rat Model of Neuropathic Pain
Amin, B., Hajhashemi, V., Abnous, K., & Hosseinzadeh, H. (2014) · BioMed Research International · doi:10.1155/2014/937568 · Cited by 34
Tannic acid facilitates expression of the polypyrimidine tract binding protein and alleviates deleterious inclusion of CHRNA1 exon P3A due to an hnRNP H-disrupting mutation in congenital myasthenic syndrome
Bian, Y., Masuda, A., Matsuura, T., Ito, M., Okushin, K., Engel, A. G., & Ohno, K. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp023 · Cited by 34
Brain endothelial cells induce astrocytic expression of the glutamate transporter GLT ‐1 by a Notch‐dependent mechanism
Lee, M. L., Martínez‐Lozada, Z., Krizman, E. N., & Robinson, M. B. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14135 · Cited by 34
Indole-3-Propionic Acid, a Gut Microbiota Metabolite, Protects Against the Development of Postoperative Delirium
Zhou, X., Wu, X., Wu, Y. T., Yang, L., Shi, E., Ding, W., Chen, L., Shi, X., Feng, X., Su, C., et al. (2023) · Annals of Surgery · doi:10.1097/sla.0000000000005886 · Cited by 35
Metabolic Reprogramming in Gliocyte Post-cerebral Ischemia/ Reperfusion: From Pathophysiology to Therapeutic Potential
Gong, L., Liang, J., Xie, L., Zhang, Z., Mei, Z., & Zhang, W. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666240131121032 · Cited by 36
Therapeutic approaches to preventing cell death in Huntington disease
Kaplan, A. R., & Stockwell, B. R. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.08.004 · Cited by 32
Dysregulation of Corticostriatal Ascorbate Release and Glutamate Uptake in Transgenic Models of Huntington's Disease
Rebec, G. V. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5387 · Cited by 33
Potential Therapeutic Drugs and Methods for the Treatment of Amyotrophic Lateral Sclerosis
Yacila, G., & Sari, Y. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140601162710 · Cited by 33
Gold-catalyzed heterocyclizations in alkynyl- and allenyl-β-lactams
Alcaide, B., & Almendros, P. (2011) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.7.73 · Cited by 33
Ceftriaxone reduces alcohol intake in outbred rats while upregulating xCT in the nucleus accumbens core
Stennett, B., Frankowski, J. C., Peris, J., & Knackstedt, L. A. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.07.001 · Cited by 33
Neurobiological activity of Parawixin 10, a novel anticonvulsant compound isolated from Parawixia bistriata spider venom (Araneidae: Araneae)
Fachim, H., Cunha, A. O. S., Pereira, A., Beleboni, R. O., Gobbo‐Neto, L., Lopes, N. P., Coutinho‐Netto, J., & dos Santos, W. F. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.05.008 · Cited by 33
A cell-based fascin bioassay identifies compounds with potential anti-metastasis or cognition-enhancing functions
Kraft, R., Kahn, A., Medina‐Franco, J. L., Orlowski, M. L., Baynes, C., López-Vallejo, F., Barnard, K., Maggiora, G. M., & Restifo, L. L. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.008243 · Cited by 33
Label-Free Proteomic Analysis of Protein Changes in the Striatum during Chronic Ethanol Use and Early Withdrawal
Ayers-Ringler, J. R., Oliveros, A., Qiu, Y., Lindberg, D. M., Hinton, D. J., Moore, R. M., Dasari, S., & Choi, D. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00046 · Cited by 35
Clinical Research on Traditional Chinese Medicine compounds and their preparations for Amyotrophic Lateral Sclerosis
Zhu, J., Shen, L., Lin, X., Hong, Y., & Feng, Y. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.09.135 · Cited by 33
Altered glutamate clearance in ascorbate deficient mice increases seizure susceptibility and contributes to cognitive impairment in APP/PSEN1 mice
Mi, D. J., Dixit, S., Warner, T. A., Kennard, J. A., Scharf, D. A., Kessler, E. S., Moore, L. M., Consoli, D. C., Bown, C. W., Dukes, A. J., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.08.002 · Cited by 33
TNFR1 mediates increased neuronal membrane EAAT3 expression after in vivo cerebral ischemic preconditioning
Pradillo, J. M., Hurtado, O., Romera, C., Cardenas, A. J., Fernández-Tomé, P., Alonso‐Escolano, D., Lorenzo, P. L., Moro, M. Á., & Lizasoaín, I. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.12.010 · Cited by 33
Astroglial functions
Verkhratsky, A., & Butt, A. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821565-4.00008-0 · Cited by 31
Paradoxical roles of serine racemase and d ‐serine in the G93A mSOD1 mouse model of amyotrophic lateral sclerosis
Thompson, M. M., Marecki, J. C., Marinesco, S., Labrie, V., Roder, J., Barger, S. W., & Crow, J. P. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07601.x · Cited by 32
Moving forward in clinical trials for ALS: motor neurons lead the way please
Genç, B., & Özdinler, P. H. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.10.014 · Cited by 35
Diagnostic Issues in Early-Onset Obsessive-Compulsive Disorder and their Treatment Implications
Burchi, E., & Pallanti, S. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180426151746 · Cited by 32
Pharmacological upregulation of GLT-1 alleviates the cognitive impairments in the animal model of temporal lobe epilepsy
Ramandi, D., Salmani, M. E., Moghimi, A., Lashkarbolouki, T., & Fereidoni, M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246068 · Cited by 32
Drug repurposing strategies of relevance for Parkinson’s disease
Fletcher, E. J. R., Kaminski, T. W., Williams, G. H., & Duty, S. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.841 · Cited by 31
Smoothened is a therapeutic target for reducing glutamate toxicity in ischemic stroke
Wang, Y., Lu, S., Chen, Y., Li, L., Li, X., Qu, Z., Huang, J., Fan, L., Yuan, C., Song, N., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aba3444 · Cited by 32
Neuroprotective Effects of Ceftriaxone Involve the Reduction of Aβ Burden and Neuroinflammatory Response in a Mouse Model of Alzheimer’s Disease
Tikhonova, M. A., Amstislavskaya, T. G., Ho, Y., Akopyan, A. A., Tenditnik, M. V., Ovsyukova, M. V., Bashirzade, A. A., Dubrovina, N. I., & Aftanas, L. I. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.736786 · Cited by 33
Estrogen Attenuates Manganese-Induced Glutamate Transporter Impairment in Rat Primary Astrocytes
Lee, E.-S., Sidoryk‐Wȩgrzynowicz, M., Farina, M., da Rocha, J. B. T., & Aschner, M. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9347-2 · Cited by 32
Strategies for clinical approach to neurodegeneration in Amyotrophic lateral sclerosis.
Carlesi, C., Pasquali, L., Piazza, S., Gerfo, A. L., Ienco, E. C., Alessi, R., Fornai, F., & Siciliano, G. (2011) · PubMed · doi:10.4449/aib.v149i1.1267 · Cited by 33
Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake
Gentile, A., Musella, A., Vito, F. D., Fresegna, D., Bullitta, S., Rizzo, F. R., Centonze, D., & Mandolesi, G. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-017-1048-6 · Cited by 32
Strategic approaches to developing drug treatments for ALS
Vincent, A. M., Sakowski, S. A., Schuyler, A. D., & Feldman, E. L. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.011 · Cited by 32
Current clinical trials in amyotrophic lateral sclerosis
Bhatt, J. M., & Gordon, P. H. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.8.1197 · Cited by 32
A retrospective review of the progress in amyotrophic lateral sclerosis drug discovery over the last decade and a look at the latest strategies
DeLoach, A., Cozart, M. A., Kiaei, A., & Kiaei, M. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1067197 · Cited by 36
Glial cell changes in epilepsy: Overview of the clinical problem and therapeutic opportunities
Hubbard, J. A., Hsu, M. S., Fiacco, T. A., & Binder, D. K. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.01.017 · Cited by 31
Long-term depression induced by endogenous cannabinoids produces neuroprotection via astroglial CB 1 R after stroke in rodents
Wang, F., Han, J., Higashimori, H., Wang, J., Liu, J., Li, T., Yang, Y., Dong, H., Zhang, X., & Xiong, L. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18755661 · Cited by 30
On the Common Journey of Neural Cells through Ischemic Brain Injury and Alzheimer’s Disease
Kriška, J., Heřmanová, Z., Knotek, T., Turečková, J., & Anděrová, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189689 · Cited by 33
Clozapine induces astrocyte-dependent FDG-PET hypometabolism
Rocha, A., Bellaver, B., Souza, D. G., Schu, G., Fontana, I. C., Venturin, G. T., Greggio, S., Fontella, F. U., Schiavenin, M. L., Machado, L. S., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05682-3 · Cited by 31
Transient striatal GLT-1 blockade increases EAAC1 expression, glutamate reuptake, and decreases tyrosine hydroxylase phosphorylation at ser19
Salvatore, M. F., Davis, R. W., Arnold, J. C., & Chotibut, T. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.01.012 · Cited by 31
Riluzole increases glutamate uptake by cultured C6 astroglial cells
Dall'Igna, O. P. P., Bobermin, L. D., Souza, D. O., & Quincozes‐Santos, A. (2013) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2013.06.002 · Cited by 31
GLT-1 overexpression attenuates bladder nociception and local/cross-organ sensitization of bladder nociception
Yang, M., Roman, K., Chen, D.-F., Wang, Z.-G., Lin, Y., & Stephens, R. L. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00009.2011 · Cited by 31
Astrocyte Dysfunction in Epilepsy
Steinhäuser, C., & Seifert, G. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199746545.003.0047 · Cited by 33

Authors: Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D. S., Toan, S. V., Bruijn, L. I., Su, Z.-Z., Gupta, P., & Fisher, P. B.
Affiliations: Johns Hopkins University (US)
Amyotrophic Lateral Sclerosis Association (US)
Columbia University Irving Medical Center (US)
Corresponding author: Rothstein, Jeffrey D.
ORCID: Rothstein, Jeffrey D.
Huang, Yanhua H.
Bergles, Dwight E.
Gupta, Pankaj
Fisher, Paul B.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2005-01
Volume: 433
Issue: 7021
Pages: 73-77
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature03180
OpenAlex: W2083204774
Cited by: 1,518
References: 27
Citations by year: 2026: 49 · 2025: 52 · 2024: 47 · 2023: 48 · 2022: 53 · 2021: 55 · 2020: 60 · 2019: 56 · 2018: 52 · 2017: 76 · 2016: 85 · 2015: 84 · 2014: 107 · 2013: 96 · 2012: 98
FWCI: 31.20
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: Muscular Dystrophy Association
Johns Hopkins University
Robert Packard Center for ALS Research, Johns Hopkins University
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
Keywords: beta-lactam antibiotics, ceftriaxone, penicillin, GLT-1, glutamate transporters, neuroprotection, glutamate excitotoxicity, amyotrophic lateral sclerosis, ischemic brain injury, motor neuron degeneration, drug repurposing, transcriptional activation, astrocytes
MeSH terms: Animals, Anti-Bacterial Agents, Ceftriaxone, Cell Count, Cells, Cultured, Central Nervous System, Drug Evaluation, Preclinical, Gene Expression Regulation, Mice, Transgenic, Motor Neurons, Penicillins, Promoter Regions, Genetic, RNA, Messenger, United States, United States Food and Drug Administration, Transcriptional Activation, Genes, Reporter, Neuroprotective Agents, Ischemic Preconditioning, Excitatory Amino Acid Transporter 2, beta-Lactams, Mice, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks